IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE:IQV ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants Ari Bousbib - CEO & Chairman Kerri Joseph - Corporate Participant SVP of Investment Relation & Treasury - Corporate Participant Ronald E. Bruehlman - Executive VP & CFO Conference Call Participants Ann Kathleen Hynes - Mizuho Securities USA LLC, Research Division Christine Rains - William Blair & Company L.L.C.
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y
IQV tops second-quarter 2025 estimates, with earnings up 6.4% and revenue rising 5.5%. It cuts the 2025 EBITDA guidance.
Top Stock Movers Now: GM, Lockheed Martin, IQVIA, DR Horton, and More
Major U.S. equities indexes were mixed at midday Tuesday as investors digested the latest corporate earnings. The Dow was higher, but the S&P 500 and Nasdaq lost ground.
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.64 per share a year ago.
Countdown to IQVIA (IQV) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of IQVIA (IQV) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?
IQV is set to report Q2 results on July 22, with both earnings and revenues expected to rise on strong demand across segments.
IQVIA: Competition Is Creating More Challenges Over The Long Haul
I rate IQVIA as a hold due to long-term competitive threats, particularly from one player, and concerns about capital allocation and high debt. IQVIA's business model is solid, but declining gross margins, low ROIC, and slow innovation raise concerns about its ability to sustain long-term value. The competitor's more innovative, integrated ecosystem and better capital discipline position it to capture market share from IQVIA, especially among small biotechs and large pharma.
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends
Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
IQVIA: Q1 Earnings Support Steady Optimism
IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions segment, despite market pessimism. The company's profitability remains robust with adjusted EBITDA of $883M and a 6.3% increase in adjusted EPS, supported by high cash flow conversion. IQVIA's active share repurchase program and raised full-year revenue guidance highlight management's confidence in weathering sector volatility and macroeconomic headwinds.
IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
